Clinical Trial Update: CCK1R Function in Patient Leukocytes

View source ↗

Summary

Completed clinical trial evaluating cholecystokinin 1 receptor (CCK1R) function in leukocytes of patients with obesity and type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome
• Obesity
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Mayo Clinic | Conditions: Obesity, Diabetes Mellitus, Type 2 | Status: COMPLETED